STAT
SEPTEMBER 5, 2023
The recently approved RSV vaccines have been celebrated as key public health tools, but some vaccine experts have lamented one aspect of the trials that led to their approval — namely, that older adults were largely left out of them. People who are immunocompromised and those who live in nursing homes were also not included.
STAT
SEPTEMBER 6, 2023
The recently approved RSV vaccines have been celebrated as key public health tools, but some vaccine experts have lamented one aspect of the clinical trials that led to their approval — namely, that older adults were largely left out of them , STAT tells us. Among Continue to STAT+ to read the full story…
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmacy Times
JANUARY 3, 2024
The study highlights the ongoing need for health care providers to recommend respiratory illness vaccinations to increase protection among nursing home residents during the peak season of infection.
NY Times
DECEMBER 18, 2020
The Food and Drug Administration authorized a second coronavirus vaccine for emergency use, clearing the way for millions more Americans to be immunized next week.
Eye on FDA
DECEMBER 15, 2021
We now have multiple vaccines – mRNA and traditional in the U.S. Today CDC provided important insight into the ability of the new variant to make headway with a highly vulnerable population when it released data on infections in the nursing home environment. and an even greater array outside the U.S.
NY Times
DECEMBER 3, 2020
If approved, the first batch of vaccine could arrive in the state on Dec. 15, the governor said, and contain enough doses for 170,000 people.
Pharmacy Times
AUGUST 9, 2024
The panel of healthcare professionals examines how strategic vaccination can effectively mitigate pneumococcal outbreaks, thereby reducing exposure risks to vulnerable populations in healthcare settings such as nursing homes and hospitals.
Expert insights. Personalized for you.
331 
Let's personalize your content